Breaking News

Roche Licenses Two BMS Drugs

To pay $470 million for neurodegenerative disorder drug and muscle-wasting disease drug

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters